Sbroma Tomaro E, Pippi R, Reginato E, Aiello C, Buratta L, Mazzeschi C, Perrone C, Ranucci C, Tirimagni A, Russo A, Fatone C, Fanelli C, De Feo P
Healthy Lifestyle Institute, C.U.R.I.A.Mo. (Centro Universitario Ricerca Interdipartimentale Attività Motoria), University of Perugia, Via G. Bambagioni, 19 06126 Perugia, Italy.
Healthy Lifestyle Institute, C.U.R.I.A.Mo. (Centro Universitario Ricerca Interdipartimentale Attività Motoria), University of Perugia, Via G. Bambagioni, 19 06126 Perugia, Italy.
Nutr Metab Cardiovasc Dis. 2017 Aug;27(8):688-694. doi: 10.1016/j.numecd.2017.06.009. Epub 2017 Jun 21.
It is unknown whether lifestyle change is effective in people with type 2 diabetes with inadequate glucose control. The aim of this study was to asses, in a group of people with type 2 diabetes, the impact of baseline values of glycosylated haemoglobin (HbA1c) on the effects of an intensive lifestyle intervention on metabolic, clinical and strength parameters.
222 people with type 2 diabetes with mean ± standard deviation baseline HBA1c of 7.50% ± 1.27 (range 5.1-12.7%), were enrolled in a 3-month structured multidisciplinary lifestyle intervention. Anthropometric, biochemical, clinical and fitness measurements were collected at baseline, at the end of the lifestyle intervention program and at two-year follow-up visit. Significant improvements in glycometabolic control (HbA1c: p ≤ 0.0001); anthropometric parameters (BMI p ≤ 0.0001; waist circumference: p ≤ 0.0001); and systemic blood pressure (p ≤ 0.0001) were observed both at the end of the three month intensive lifestyle program and at the two-year follow up visit. In addition, defined daily doses of hypoglycaemic treatment significantly decreased (p = 0.001). Fitness measures exhibited significant increments in the whole sample at the end of the intensive intervention program (p ≤ 0.0001). When patients were divided into tertiles considering the baseline value of HbA1c, the most marked improvements in HbA1c, blood glucose and triglycerides were observed in the group with inadequate glucose control (Hba1c ≥ 7.71%), both at the three-month and two-year follow-ups.
These results demonstrate that an intensive lifestyle intervention should be recommended for people with type 2 diabetes, particularly those with the most inadequate glycaemic control.
CURIAMO trial was registered in the Australian New Zealand Clinical Trials Registry, (ACTRN12611000255987).
生活方式改变对血糖控制不佳的2型糖尿病患者是否有效尚不清楚。本研究的目的是评估一组2型糖尿病患者中糖化血红蛋白(HbA1c)的基线值对强化生活方式干预在代谢、临床和力量参数方面效果的影响。
222名2型糖尿病患者,其基线糖化血红蛋白(HBA1c)平均值±标准差为7.50%±1.27(范围5.1 - 12.7%),参加了为期3个月的结构化多学科生活方式干预。在基线、生活方式干预项目结束时以及两年随访时收集人体测量、生化、临床和体能测量数据。在三个月强化生活方式项目结束时和两年随访时,均观察到糖代谢控制(HbA1c:p≤0.0001)、人体测量参数(BMI:p≤0.0001;腰围:p≤0.0001)和全身血压(p≤0.0001)有显著改善。此外,降糖治疗的规定日剂量显著降低(p = 0.001)。在强化干预项目结束时,整个样本的体能测量显示有显著增加(p≤0.0001)。当根据HbA1c的基线值将患者分为三分位数时,在血糖控制不佳组(Hba1c≥7.71%)中,无论是在三个月和两年随访时,HbA1c、血糖和甘油三酯的改善最为明显。
这些结果表明,应建议2型糖尿病患者,特别是血糖控制最不佳的患者进行强化生活方式干预。
CURIAMO试验在澳大利亚新西兰临床试验注册中心注册(ACTRN12611000255987)